Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Rec...
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
About this item
Full title
Author / Creator
Faloppi, Luca , Puzzoni, Marco , Casadei Gardini, Andrea , Silvestris, Nicola , Masi, Gianluca , Marisi, Giorgia , Vivaldi, Caterina , Gadaleta, Cosmo Damiano , Ziranu, Pina , Bianconi, Maristella , Loretelli, Cristian , Demurtas, Laura , Lai, Eleonora , Giampieri, Riccardo , Galizia, Eva , Ulivi, Paola , Battelli, Nicola , Falcone, Alfredo , Cascinu, Stefano and Scartozzi, Mario
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Sorafenib represents one of the therapeutic strongholds for advanced hepatocellular carcinoma (HCC), but unfortunately, predictive factors are lacking. We previously reported that the
VEGF
single nucleotide polymorphisms (SNPs) rs2010963 and rs4604006 might correlate with clinical outcomes in sorafenib-treated HCC patients.
O...
Alternative Titles
Full title
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
Authors, Artists and Contributors
Author / Creator
Puzzoni, Marco
Casadei Gardini, Andrea
Silvestris, Nicola
Masi, Gianluca
Marisi, Giorgia
Vivaldi, Caterina
Gadaleta, Cosmo Damiano
Ziranu, Pina
Bianconi, Maristella
Loretelli, Cristian
Demurtas, Laura
Lai, Eleonora
Giampieri, Riccardo
Galizia, Eva
Ulivi, Paola
Battelli, Nicola
Falcone, Alfredo
Cascinu, Stefano
Scartozzi, Mario
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2694702845
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2694702845
Other Identifiers
ISSN
1776-2596
E-ISSN
1776-260X
DOI
10.1007/s11523-020-00698-x
